Small molecule-mediated restoration of airway surface physiology in human cystic fibrosis lung epithelia
US11850256B2 · kind B2 · utility
1Cited by
3References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 1, 2021 |
| Grant date | Dec 26, 2023 |
| Priority date | — |
| Expiry date | Sep 11, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H17/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are complexes comprising amphotericin B (AmB) or derivatives and sterols. Also provided herein are methods of treating cystic fibrosis using AmB or complexes comprising AmB or derivatives and sterols.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.